Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 17, 2021 - Issue 1
618
Views
8
CrossRef citations to date
0
Altmetric
Services & Policy

Impact of Substance Use Disorder on Quality of Inpatient Mental Health Services for People With Anxiety and Depression

, MRCPsych, MBBS, MA, BA, , DClinPsych, BA, , MSc, BA, , MA, BA, , MA, BA, , PhD, MA, BSc, , FRCPsych, MD, MBBS & , FRCPsych, MD, MBBS show all

References

  • Albery, I. P., Heuston, J., Ward, J., Groves, P., Durand, M. A., Gossop, M., & Strang, J. (2003). Measuring therapeutic attitude among drug workers. Addictive Behaviors, 28(5), 995–1005. https://doi.org/10.1016/s0306-4603(01)00288-x
  • Babowitch, J. D., & Antshel, K. M. (2016). Adolescent treatment outcomes for comorbid depression and substance misuse: A systematic review and synthesis of the literature. Journal of Affective Disorders, 201, 25–33. https://doi.org/10.1016/j.jad.2016.04.018
  • Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., Sly, K., Devir, H., & Terry, M. (2002). Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica, 106(3), 233–240. https://doi.org/10.1034/j.1600-0447.2002.01118.x
  • Barlow, K., Grenyer, B., & Ilkiw-Lavalle, O. (2000). Prevalence and precipitants of aggression in psychiatric inpatient units. The Australian and New Zealand Journal of Psychiatry, 34(6), 967–974. https://doi.org/10.1080/000486700271
  • Barry, K. R., Tudway, J. A., & Blissett, J. (2002). Staff drug knowledge and attitudes towards drug use among the mentally ill within a medium secure psychiatric hospital. Journal of Substance Use, 7(1), 50–56. https://doi.org/10.1080/14659890110110365
  • Bartlett, C., Evans, M., Holloway, J., O'Connor, S., & Harrison, G. (1999). Markers of inappropriate placement in acute psychiatric inpatient care: A five hospital study. Social Psychiatry and Psychiatric Epidemiology, 34(7), 367–375. https://doi.org/10.1007/s001270050157
  • Brown, R. A., & Ramsey, S. E. (2000). Addressing comorbid depressive symptomatology in alcohol treatment. Professional Psychology: Research and Practice, 31(4), 418–422. https://doi.org/10.1037/0735-7028.31.4.418
  • Brown, S., O’Rourke, S., & Schwannauer, M. (2019). Risk factors for inpatient violence and self-harm in forensic psychiatry: The role of head injury, schizophrenia and substance misuse. Brain Injury, 33(3), 313–321. https://doi.org/10.1080/02699052.2018.1553064
  • Carey, T. L. (2018). Use of antidepressants in patients withco-occurring depression and substance use disorders. In Handbook of experimental pharmacology (pp. 359–370). Springer Publishing.
  • Clarke, D. E., Gonzalez, M., Pereira, A., Boyce-Gaudreau, K., Waldman, C., & Demczuk, L. (2015). The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: A quantitative systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 13(10), 133–145. https://doi.org/10.11124/jbisrir-2015-2203
  • Cornelius, J. R., Salloum, I. M., Ehler, J. G., Jarrett, P. J., Cornelius, M. D., Perel, J. M., Thase, M. E., & Black, A. (1997). Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Archives of General Psychiatry, 54(8), 700–705. https://doi.org/10.1001/archpsyc.1997.01830200024004
  • Deckert, J., & Erhardt, A. (2019). Predicting treatment outcome for anxiety disorders with or without comorbid depression using clinical, imaging and (epi)genetic data. Current Opinion in Psychiatry, 32(1), 1–6. https://doi.org/10.1097/YCO.0000000000000468
  • Department of Health and Social Care. (2017). Drug misuse and dependence: UK guidelines on clinical management. https://www.gov.uk/government/publications/drug-misuse-and-dependence-uk-guidelines-on-clinical-management
  • Ding, L., Landon, B. E., Wilson, I. B., Wong, M. D., Shapiro, M. F., & Cleary, P. D. (2005). Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Archives of Internal Medicine, 165(6), 618–623. https://doi.org/10.1001/archinte.165.6.618
  • Dolan, M., & Kirwan, H. (2001). Survey of staff perceptions of illicit drug use among patients in a medium secure unit. Psychiatric Bulletin, 25(1), 14–17. https://doi.org/10.1192/pb.25.1.14
  • Drummond, C. (2017). Cuts to addiction services are a false economy. BMJ, 357, j2704. https://doi.org/10.1136/bmj.j2704
  • Ford, R., Bammer, G., & Becker, N. (2008). The determinants of nurses' therapeutic attitude to patients who use illicit drugs and implications for workforce development. Journal of Clinical Nursing, 17(18), 2452–2462. https://doi.org/10.1111/j.1365-2702.2007.02266.x
  • Grant, B. F. (1995). Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. Journal of Substance Abuse, 7(4), 481–497. https://doi.org/10.1016/0899-3289(95)90017-9
  • Hawton, K., Casañas I Comabella, C., Haw, C., & Saunders, K. (2013). Risk factors for suicide in individuals with depression: A systematic review. Journal of Affective Disorders, 147(1–3), 17–28. https://doi.org/10.1016/j.jad.2013.01.004
  • Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry, 9, 6. https://doi.org/10.1186/1471-244X-9-6
  • Hoff, R. A., & Rosenheck, R. A. (1999). The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services, 50(10), 1309–1315. https://doi.org/10.1176/ps.50.10.1309
  • Hölzel, L., Härter, M., Reese, C., & Kriston, L. (2011). Risk factors for chronic depression-a systematic review. Journal of Affective Disorders, 129(1–3), 1–13. https://doi.org/10.1016/j.jad.2010.03.025
  • Howard, M. O., & Chung, S. S. (2000). Nurses' attitudes toward substance misusers. I. Surveys. Substance Use & Misuse, 35(3), 347–365. https://doi.org/10.3109/10826080009147701
  • Howard, V., & Holmshaw, J. (2010). Inpatient staff perceptions in providing care to individuals with co-occurring mental health problems and illicit substance use. Journal of Psychiatric and Mental Health Nursing, 17(10), 862–872. https://doi.org/10.1111/j.1365-2850.2010.01620.x
  • Huntley, D. A., Cho, D. W., Christman, J., & Csernansky, J. G. (1998). Predicting length of stay in an acute psychiatric hospital. Psychiatric Services, 49(8), 1049–1053. https://doi.org/10.1176/ps.49.8.1049
  • IBM Corp. (2017). IBM SPSS Statistics for Window., Version 25. IBM Corp.
  • Jané-Llopis, E., & Matytsina, I. (2006). Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 515–536. https://doi.org/10.1080/09595230600944461
  • Johns, A. (1997). Substance misuse: A primary risk and a major problem of comorbidity. International Review of Psychiatry, 9(2–3), 233–241. https://doi.org/10.1080/09540269775448
  • Kelleher, S. (2007). Health care professionals' knowledge and attitudes regarding substance use and substance users. Accident and Emergency Nursing, 15(3), 161–165. https://doi.org/10.1016/j.aaen.2007.05.005
  • Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. https://doi.org/10.1001/archpsyc.62.6.593
  • Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54(4), 313–321. https://doi.org/10.1001/archpsyc.1997.01830160031005
  • King, C. A., Horwitz, A., Czyz, E., & Lindsay, R. (2017). Suicide risk screening in healthcare settings: Identifying males and females at risk. Journal of Clinical Psychology in Medical Settings, 24(1), 8–20. https://doi.org/10.1007/s10880-017-9486-y
  • Lingford-Hughes, A. R., Welch, S., & Nutt, D. J. (2004). Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 18(3), 293–335. https://doi.org/10.1177/026988110401800321
  • Long, C. G., & Hollin, C. R. (2009). Assessing comorbid substance use in detained psychiatric patients: Issues and instruments for evaluating treatment outcome. Substance Use & Misuse, 44(11), 1602–1641. https://doi.org/10.1080/10826080802486434
  • Luoma, J. B., Twohig, M. P., Waltz, T., Hayes, S. C., Roget, N., Padilla, M., & Fisher, G. (2007). An investigation of stigma in individuals receiving treatment for substance abuse. Addictive Behaviors, 32(7), 1331–1346. https://doi.org/10.1016/j.addbeh.2006.09.008
  • Martino, S., Zimbrean, P., Forray, A., Kaufman, J. S., Desan, P. H., Olmstead, T. A., Gilstad-Hayden, K., Gueorguieva, R., & Yonkers, K. A. (2019). Implementing motivational interviewing for substance misuse on medical inpatient units: A randomized controlled trial. Journal of General Internal Medicine, 34(11), 2520–2529. https://doi.org/10.1007/s11606-019-05257-3
  • McGrath, P. J., Nunes, E. V., Stewart, J. W., Goldman, D., Agosti, V., Ocepek-Welikson, K., & Quitkin, F. M. (1996). Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial. Archives of General Psychiatry, 53(3), 232–240. https://doi.org/10.1001/archpsyc.1996.01830030054009
  • Miller, W. R., & Rose, G. S. (2009). Toward a theory of motivational interviewing. The American Psychologist, 64(6), 527–537. https://doi.org/10.1037/a0016830
  • Mitchell, A. J., Malone, D., & Doebbeling, C. C. (2009). Quality of medical care for people with and without comorbid mental illness and substance misuse: Systematic review of comparative studies. The British Journal of Psychiatry: The Journal of Mental Science, 194(6), 491–499. https://doi.org/10.1192/bjp.bp.107.045732
  • Mohammadi, D. (2014). Addiction services in England: In need of an intervention. The Lancet. Psychiatry, 1(6), 421–422. https://doi.org/10.1016/S2215-0366(14)00015-7
  • National Institute for Health and Care Excellence. (2011a). Common mental health problems: Identification and pathways to care (CG123). https://www.nice.org.uk/guidance/CG123
  • National Institute for Health and Care Excellence. (2011b). Service user experience in adult mental health: Improving the experience of care for people using adult NHS mental health services (CG136). https://www.nice.org.uk/guidance/cg136
  • National Institute for Health and Care Excellence. (2016). Transition between inpatient mental health settings and community or care home settings (NG53). https://www.nice.org.uk/guidance/ng53
  • Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA, 291(15), 1887–1896. https://doi.org/10.1001/jama.291.15.1887
  • Nunes, E. V., Quitkin, F. M., Donovan, S. J., Deliyannides, D., Ocepek-Welikson, K., Koenig, T., Brady, R., McGrath, P. J., & Woody, G. (1998). Imipramine treatment of opiate-dependent patients with depressive disorders: A placebo-controlled trial. Archives of General Psychiatry, 55(2), 153–160. https://doi.org/10.1001/archpsyc.55.2.153
  • Palmer, R. S., Murphy, M. K., Piselli, A., & Ball, S. A. (2009). Substance user treatment dropout from client and clinician perspectives: A pilot study. Substance Use & Misuse, 44(7), 1021–1038. https://doi.org/10.1080/10826080802495237
  • Peckover, S., & Chidlaw, R. G. (2007). Too frightened to care? Accounts by district nurses working with clients who misuse substances. Health & Social Care in the Community, 15(3), 238–245. https://doi.org/10.1111/j.1365-2524.2006.00683.x
  • Perry, S., Frances, A., Klar, H., & Clarkin, J. (1983). Selection criteria for individual dynamic psychotherapies. The Psychiatric Quarterly, 55(1), 3–16. https://doi.org/10.1007/BF01064832
  • Pompili, M., Serafini, G., Del Casale, A., Rigucci, S., Innamorati, M., Girardi, P., Tatarelli, R., & Lester, D. (2009). Improving adherence in mood disorders: The struggle against relapse, recurrence and suicide risk. Expert Review of Neurotherapeutics, 9(7), 985–1004. https://doi.org/10.1586/ern.09.62
  • Pompili, M., Venturini, P., Palermo, M., Stefani, H., Seretti, M. E., Lamis, D. A., Serafini, G., Amore, M., & Girardi, P. (2013). Mood disorders medications: Predictors of nonadherence - review of the current literature. Expert Review of Neurotherapeutics, 13(7), 809–825. https://doi.org/10.1586/14737175.2013.811976
  • Prochaska, J. J., Gill, P., Hall, S. E., & Hall, S. M. (2005). Identification and treatment of substance misuse on an inpatient psychiatry unit. Psychiatric Services, 56(3), 347–349. https://doi.org/10.1176/appi.ps.56.3.347
  • Public Health England. (2016). Public health profiles. https://fingertips.phe.org.uk/search/anxiety#page/3/gid/1/pat/6/par/E12000004/ati/102/are/E06000015/iid/90647/age/168/sex/4
  • Public Health England. (2017). Public health profiles. https://fingertips.phe.org.uk/search/depression#page/3/gid/1/pat/6/par/E12000004/ati/102/are/E06000015/iid/90578/age/1/sex/4
  • Royal College of Psychiatrists – College Centre for Quality Improvement. (2017). Standards for Inpatient Mental Health Services, second edition. https://www.rcpsych.ac.uk/improving-care/ccqi/resources/core-standards-project.
  • Royal College of Psychiatrists. (2019a). How are inpatient mental health services for people with anxiety and depression performing? Main findings from the National Clinical Audit of Anxiety and Depression: A report co-produced with service users and carers. https://www.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/national-clinical-audits/ncaad-documents/ncaad-main-report.pdf
  • Royal College of Psychiatrists. (2019b). Statistical report - Analysis examining inter-rater reliability for Core Audit data from National Clinical Audit of Anxiety and Depression. https://itineris.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/national-clinical-audits/ncaad-documents/ncaad-inter-rater-report.pdf?sfvrsn=6ff443fc_2
  • Roy-Byrne, P. P., Pages, K. P., Russo, J. E., Jaffe, C., Blume, A. W., Kingsley, E., Cowley, D. S., & Ries, R. K. (2000). Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 20(2), 129–136. https://doi.org/10.1097/00004714-200004000-00003
  • Runeson, B., Odeberg, J., Pettersson, A., Edbom, T., Jildevik Adamsson, I., & Waern, M. (2017). Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence. PloS One, 12(7), e0180292. https://doi.org/10.1371/journal.pone.0180292
  • Saraceno, L., Munafó, M., Heron, J., Craddock, N., & van den Bree, M. B. M. (2009). Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: A review. Addiction, 104(7), 1100–1121. https://doi.org/10.1111/j.1360-0443.2009.02571.x
  • Schomerus, G., Corrigan, P. W., Klauer, T., Kuwert, P., Freyberger, H. J., & Lucht, M. (2011). Self-stigma in alcohol dependence: Consequences for drinking-refusal self-efficacy. Drug and Alcohol Dependence, 114(1), 12–17. https://doi.org/10.1016/j.drugalcdep.2010.08.013
  • Scott, J., Gilvarry, E., & Farrell, M. (1998). Managing anxiety and depression in alcohol and drug dependence. Addictive Behaviors, 23(6), 919–931. https://doi.org/10.1016/S0306-4603(98)00074-4
  • Sher, L. (2006). Alcoholism and suicidal behavior: A clinical overview. Acta Psychiatrica Scandinavica, 113(1), 13–22. https://doi.org/10.1111/j.1600-0447.2005.00643.x
  • Sinclair, J. M. A., Latifi, A. H., & Latifi, A. W. (2008). Co-morbid substance misuse in psychiatric patients: Prevalence and association with length of inpatient stay. Journal of Psychopharmacology, 22(1), 92–99. https://doi.org/10.1177/0269881107082029
  • Sullivan, L. E., Fiellin, D. A., & O'Connor, P. G. (2005). The prevalence and impact of alcohol problems in major depression: A systematic review. The American Journal of Medicine, 118(4), 330–341. https://doi.org/10.1016/j.amjmed.2005.01.007
  • Thornicroft, G., Rose, D., & Kassam, A. (2007). Discrimination in health care against people with mental illness. International Review of Psychiatry, 19(2), 113–122. https://doi.org/10.1080/09540260701278937
  • Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depression and Anxiety, 35(9), 851–860. https://doi.org/10.1002/da.22771
  • van Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1–2), 23–35. https://doi.org/10.1016/j.drugalcdep.2013.02.018
  • Virtanen, S., Kuja-Halkola, R., Mataix-Cols, D., Jayaram-Lindström, N., D'Onofrio, B. M., Larsson, H., Rück, C., Suvisaari, J., Lichtenstein, P., & Latvala, A. (2020). Comorbidity of substance misuse with anxiety-related and depressive disorders: A genetically informative population study of 3 million individuals in Sweden. Psychological Medicine, 50(10), 1706–1715. https://doi.org/10.1017/S0033291719001788
  • Walter, F., Carr, M. J., Mok, P. L. H., Astrup, A., Antonsen, S., Pedersen, C. B., Shaw, J., & Webb, R. T. (2017). Premature mortality among patients recently discharged from their first inpatient psychiatric treatment. JAMA Psychiatry, 74(5), 485–492. https://doi.org/10.1001/jamapsychiatry.2017.0071
  • Watkins, K. E., Burnam, A., Kung, F.-Y., & Paddock, S. (2001). A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services, 52(8), 1062–1068. https://doi.org/10.1176/appi.ps.52.8.1062
  • Weiss, R., Najavits, L., & G, H. (1998). Overview of treatment modalities for dual diagnosis patients: Pharmacotherapy, psychotherapy, and 12-step programs. In H. R. Kranzler & J. A. Tinsley (Eds.), Dual diagnosis and treatment: Substance abuse and comorbid disorders (2nd ed., pp 87–107). Marcel Dekker.
  • World Health Organization. (2017). Depression and other common mental disorders: global health estimates. https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.